微信关注
Total item
Cart Subtotal
￥ 0.00 产品详情
SR-136683是一种口服制剂，其中含有血管内皮生长因子受体（VEGFR）和血小板衍生生长因子受体（PDGFR）的小分子受体酪氨酸激酶抑制剂，具有潜在的抗肿瘤活性。
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.23 mL | 116.16 mL | 232.31 mL |
| 0.5 mM | 4.65 mL | 23.23 mL | 46.46 mL |
| 1 mM | 2.32 mL | 11.62 mL | 23.23 mL |
| 5 mM | 0.46 mL | 2.32 mL | 4.65 mL |
*The above data is based on the productmolecular weight 430.45258. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A13554 |
|---|---|
| 作用机制 | Inhibitor (抑制剂) |
| M. Wt | 430.45258 |
| Formula | C25H22N2O5 |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| CAS No. | 637774-61-9 |
| Synonyms | SR13668, SR 13668, CHEMBL245030, LS-190469 |
| SMILES | CCOC(=O)C1=CC2=C3C=C4C5=C(C=CC(=C5)C(=O)OCC)NC4=C(C3=NC2=CC1)OC |
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
AKT inhibitor VIII (AKTI-1/2)
AKT inhibitor VIII (AKTI-1/2)是一种细胞可渗透且可逆的喹喔啉化合物，在体外激酶测定中，该化合物有效和选择…
Akt1 and Akt2-IN-1
Akt1 and Akt2-IN-1是Akt1（IC50 = 3.5 nM）和Akt2（IC50 = 42 nM）的变构抑制剂，具有有效且平衡的活性。
Perifosine (NSC-639966)
Perifosine (也为KRX-0401) 充当Akt抑制剂和PI3K抑制剂。
TIC10 isomer
TIC10通过Foxo3a使Akt和ERK失活，从而诱导TRAIL，具有优越的药物特性：跨血脑屏障传递，优异的稳定性和改善…
Keywords:购买 SR-13668 | SR-13668 供应商 | 订购 SR-13668 | SR-13668 价格 | SR-13668 生产商 | 订单 SR-13668 | SR-13668 代理商 | 购买 637774-61-9| 637774-61-9 供应商 | 订购 637774-61-9 | 637774-61-9 价格 | 637774-61-9 生产商 | 订单 637774-61-9 | 637774-61-9 代理商|buy SR-13668 | SR-13668 Supplier | purchase SR-13668 | SR-13668 cost | SR-13668 manufacturer | order SR-13668 | SR-13668 distributor | buy 637774-61-9| 637774-61-9 Supplier | purchase 637774-61-9 | 637774-61-9 cost | 637774-61-9 manufacturer | order 637774-61-9 | 637774-61-9 distributor